chr3-149167992-A-ATT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_032383.5(HPS3):c.2887+18_2887+19dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0069 ( 8 hom., cov: 0)
Exomes 𝑓: 0.010 ( 18 hom. )
Consequence
HPS3
NM_032383.5 intron
NM_032383.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.188
Genes affected
HPS3 (HGNC:15597): (HPS3 biogenesis of lysosomal organelles complex 2 subunit 1) This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 3-149167992-A-ATT is Benign according to our data. Variant chr3-149167992-A-ATT is described in ClinVar as [Benign]. Clinvar id is 1169104.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00695 (1045/150398) while in subpopulation SAS AF= 0.0198 (95/4788). AF 95% confidence interval is 0.0166. There are 8 homozygotes in gnomad4. There are 540 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS3 | NM_032383.5 | c.2887+18_2887+19dupTT | intron_variant | ENST00000296051.7 | NP_115759.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS3 | ENST00000296051.7 | c.2887+18_2887+19dupTT | intron_variant | 1 | NM_032383.5 | ENSP00000296051.2 |
Frequencies
GnomAD3 genomes AF: 0.00695 AC: 1045AN: 150284Hom.: 8 Cov.: 0
GnomAD3 genomes
AF:
AC:
1045
AN:
150284
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0101 AC: 11520AN: 1137512Hom.: 18 Cov.: 18 AF XY: 0.0105 AC XY: 6037AN XY: 577410
GnomAD4 exome
AF:
AC:
11520
AN:
1137512
Hom.:
Cov.:
18
AF XY:
AC XY:
6037
AN XY:
577410
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00695 AC: 1045AN: 150398Hom.: 8 Cov.: 0 AF XY: 0.00736 AC XY: 540AN XY: 73418
GnomAD4 genome
AF:
AC:
1045
AN:
150398
Hom.:
Cov.:
0
AF XY:
AC XY:
540
AN XY:
73418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Hermansky-Pudlak syndrome Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 27, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at